BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Saccharomyces cerevisiae var boulardii {S. boulardii} - Lactobacillus panisapium |
👶
Early supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 in newborn dairy calves increases IgA production in the intestine at 1 week of age. Journal of dairy science (J Dairy Sci ) Vol: 103 Issue 9 Pages: 8615-8628 Pub: 2020 Sep Epub: 2020 Jul 16 Authors Villot C , Chen Y , Pedgerachny K , Chaucheyras-Durand F , Chevaux E , Skidmore A , Guan LL , Steele MA , Publication |
| Saccharomyces cerevisiae var boulardii {S. boulardii} - Lactobacillus panisapium |
👶
Effects of fructooligosaccharides and Saccharomyces boulardii on the compositional structure and metabolism of gut microbiota in students. Microbiological research (Microbiol Res ) Vol: 285 Issue Pages: 127741 Pub: 2024 Aug Epub: 2024 May 9 Authors Fu H , Chen Z , Teng W , Du Z , Zhang Y , Ye X , Yu Z , Zhang Y , Pi X , Publication |
| Saccharomyces cerevisiae var boulardii {S. boulardii} - Lactobacillus panisapium |
👶
Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline. Physiology & behavior (Physiol Behav ) Vol: 236 Issue Pages: 113411 Pub: 2021 Jul 1 Epub: 2021 Mar 31 Authors Roy Sarkar S , Mitra Mazumder P , Chatterjee K , Sarkar A , Adhikary M , Mukhopadhyay K , Banerjee S , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
